Glycomimetics Inc
Ticker: GLYC
| Insider | Title |
|---|---|
| Administratiekantoor Westend Stichting | 10% or greater ownership |
| Amaury Wittouck | 10% or greater ownership |
| Armand Girard | SVP, Chief Business Officer |
| Brian M. Hahn | SVP Finance, CFO |
| Bruce S Johnson | SVP Chief Commercial Officer |
| Chinmaya Rath | SVP and Chief Business Officer |
| Daniel M Junius | Director |
| Edwin Rock | Chief Medical Officer |
| Global Management, Llc Invus | 10% or greater ownership |
| Group S.a. Artal | 10% or greater ownership |
| Harout Semerjian | Chief Executive Officer, Director |
| International Management S.a. Artal | 10% or greater ownership |
| International S.c.a. Artal | 10% or greater ownership |
| John L. Magnani | SVP of Research, CSO |
| L.l.c. Siren, | 10% or greater ownership |
| Mark Alan Goldberg | Director |
| Patricia S Andrews | Director |
| Public Equities Advisors, Llc Invus | 10% or greater ownership |
| Public Equities, L.p. Invus | 10% or greater ownership |
| Rachel K. King | Director |
| Raymond Debbane | 10% or greater ownership |
| S.a. Westend | 10% or greater ownership |
| Scott D Sandell | 10% or greater ownership |
| Scott Koenig | Director |
| Scott Thomas Jackson | Director |
| Timothy R Pearson | Director |